Tackling osteoporosis – the hidden killer
29th July 2020
A Fracture Tsunami…
…is approaching and the resulting human and socioeconomic burden will have an enormous impact on all countries with ageing populations.
Gaps and Solutions in Bone Health: A Global Framework for Improvement (http://worldosteoporosisday.org/thematic-report-2016)
An estimated 3 million people in the UK have osteoporosis, with 500,000 fragility fractures a year costing the NHS more than £1bn per annum. Tragically, hip fractures have a one-year mortality rate of 33% and up to four fifths of patients will be unable to carry out at least one independent daily activity within the first year after a fracture.
Despite these sobering facts, it is estimated that 50% of people with poor bone health currently go undiagnosed, and 80% of those with a broken bone remain untreated against future fractures. A US study found that 7.2% of post menopausal women unknowingly had osteoporosis and were 350 times more likely to suffer a bone fracture within a year than women with normal bone health.
A Brighter Future for Osteoporosis
So, do things have to remain this way? With IBEX Trueview, the answer is a definitive no!
Although 50% of those with hip fractures will have had a previous fracture, the majority will not have been tested for poor bone health due to the limitations of current X-ray scans. This misses a vital early opportunity to intervene with inexpensive lifestyle changes and drug treatments before the patient suffers debilitating fractures.
IBEX Trueview uniquely measures bone health from every X-ray scan, with no change to the system or imaging protocol. This presents a unique opportunity to screen all patients presenting with a fracture for osteoporosis, regardless of age or gender and to provide timely intervention and many more decades of healthy, active life.
Or as Dr Stephen Tuck, Consultant Rheumatologist says:
“The ability to identify at risk individuals from standard X-rays has enormous potential. In many places there is a low pick-up rate for treating individuals post fracture and around the world access to DXA is limited. I am now convinced that this technology could make a major contribution to the identification of people with osteoporosis and at risk of fractures”
IBEX is seeking OEM partners to bring the Trueview Bone Health Classifier to market.
Contact us below to discuss how Trueview can bring a valuable new capability to your DR systems and help you gain market share in the competitive DR market.